Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $15.8500 (-0.44%) ($15.8500 - $16.0900) on Thu. Sep. 16, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.83% (three month average) | RSI | 71 | Latest Price | $15.8500(-0.44%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA advances 1% a day on average for past five trading days. | Weekly Trend | ATRA advances 3.3% a week on average for past two weeks. | Market Behavior | Value stocks sell-off for large cap. Value stock sell-off for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(51%) ARKG(45%) ARKK(45%) IBB(45%) IWO(43%) | Factors Impacting ATRA price | ATRA will decline at least -1.415% in a week (0% probabilities). VIXM(-37%) VXX(-27%) IGOV(-16%) UNG(-14%) TLT(-11%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.415% (StdDev 2.83%) | Hourly BBV | 0.5 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $15.84(0.06%) | 10 Day Moving Average | $15.63(1.41%) | 20 Day Moving Average | $14.85(6.73%) | To recent high | -4.3% | To recent low | 32% | Market Cap | $1.178b | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |